Cargando…
NCTD Prevents Renal Interstitial Fibrosis via Targeting Sp1/lncRNA Gm26669 Axis
In our previous study, we demonstrated that norcantharidin (NCTD) is a potential therapeutic agent for renal interstitial fibrosis (RIF). Recently, we found that lncRNA Gm26669 (Gm26669) contributed to the development of RIF and could be regulated by NCTD. However, the upstream mechanisms of Gm26669...
Autores principales: | Tian, Jiao, Xiao, Zheng, Wei, Ju, Shan, Yi, Zeng, Dong, Tao, Yilin, Fang, Xi, Tang, Chengyuan, Chen, Xiaojun, Li, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375230/ https://www.ncbi.nlm.nih.gov/pubmed/34421354 http://dx.doi.org/10.7150/ijbs.59195 |
Ejemplares similares
-
Repression of YAP by NCTD disrupts NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2016) -
Nr4a1 promotes renal interstitial fibrosis by regulating the p38 MAPK phosphorylation
por: Tao, Yilin, et al.
Publicado: (2023) -
Anp32e promotes renal interstitial fibrosis by upregulating the expression of fibrosis-related proteins
por: Wei, Ju, et al.
Publicado: (2022) -
Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells
por: Chang, Cheng, et al.
Publicado: (2010) -
Knockdown of lncRNA MALAT1 attenuates renal interstitial fibrosis through miR-124-3p/ITGB1 axis
por: Xia, Weiping, et al.
Publicado: (2023)